期刊文献+

我国大中型企业新产品产出现状研究 被引量:3

Analysis on New Product Output Current Status of Large and Medium-Sized Enterprises in China
下载PDF
导出
摘要 调查了我国大中型企业2002—2006年的新产品产出情况。我国大中型企业5年共投入新产品开发经费4289.3亿元,大中型企业制造业的医药、航空航天、电子及通信设备、电子计算机及办公设备、医疗设备及仪器仪表5个行业是新产品的主要生产者,电子及通信设备在制造业新产品开发中排列第一;新产品产值占工业总产值的比例略有下降,其中内资企业新产品产值占60.1%,港澳台和外资占39.9%;新产品出口逐年增加,新产品销售收入100687亿,其中内资企业占60%,港澳台和外资企业占40%;新产品产值占工业总产值和新产品销售收入占产品销售收入的比重,内资企业均低于全国平均水平。近年来,我国大中型企业新产品销售收入总量逐年增多,但内资企业新产品各项产出指标所占比例均偏低,因此内资企业要增强忧患意识,加大新产品开发力度。 This paper surveys the large and medium-sized enterprises new product output status in 2002-2006 in China. Large and medium-sized enterprises invested 4289.3 billion as new product development funds in the 5 years, five main producers for new product are large and medium-sized enterprises manufacturing medicine, aerospace and electronic and communication equipment, electronic computers and office equipment, medical equipment and instrument industry. The percent of new product value in the total industrial output value got a drop, the percent of mainland enterprises new product value is 60.1%, Hong Kong, Macao, Taiwan and foreign is 39.9%. The new product export increases year by year, new product sales income is 100687 billion, including domestic enterprise 60%, Hong Kong, Macao and Taiwan and foreign enterprise 40%. As for the percent of new product value in the total industrial output value and the percent of new product sales income in product sales income, domestic enterprises are lower than the national average level. Total sales income of new products in large and medium-sized enterprises increases annually, but the indexes of domestic enterprises new products' percent are low in a degree, so domestic enterprises should do more effort in new product development.
作者 汤亚非
机构地区 茂名学院图书馆
出处 《科技进步与对策》 CSSCI 北大核心 2010年第8期120-123,共4页 Science & Technology Progress and Policy
关键词 大中型企业 新产品产出 行业分布 Large and Medium-Sized Enterprises New Product Output Industry Distribution
  • 相关文献

参考文献2

二级参考文献5

共引文献3

同被引文献29

  • 1刘莹,梁毅.论药品可及性与药品专利保护[J].中国药房,2007,18(13):966-968. 被引量:13
  • 2王卉珏,谢科范.科技政策体系中的非线性特征分析[J].科学管理研究,2004,22(4):49-51. 被引量:4
  • 3张晓萌,邱家学.药品数据保护在我国的发展探讨[J].中国药房,2005,16(21):1606-1608. 被引量:9
  • 4李荫榕,邵宪文,孟庆伟.国有大中型企业自主性技术创新内部环境优化研究[J].科技管理研究,2006,26(4):90-92. 被引量:1
  • 5周楠.我国医疗器械行业技术创新特征及政策研究[D].杭州:浙江大学出版社,2008.
  • 6玉起美惠子.医薬品開発におけるフアーマコゲノミクスの現状と展望[J].The Pharmaceutical Society of Japan,2009,129(1):135-145.
  • 7Kanwar S,Evenson RE.Does intellectual property rights spur technological change[J].Oxford Economic Paper,2003,55:235-264.
  • 8柏林科学技术研究院著,吴金希等译.文化 vs 技术创新[M].北京:知识产权出版社,2006,170.
  • 9《关于医药品制造许可标准基本规定》[EB/OL].[2012-03-011 ] http ://www. rnhlw, go. jp/shingi/2009/01/dl/s0115-3b_0004. odf.
  • 10Tracey D, KlareskogL, SassoEH, et al. Tumor necrosis factor antag- onist mechanisms of action: A comprehensive review[ J]. Pharma- col Ther,2008,117 ( 2 ) :244-279.

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部